Is CLGUF or MRK a better dividend investment in 2026?

CLGUF currently yields 2336.45% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: CLGUF offers higher current income.

What is the dividend yield difference between CLGUF and MRK?

CLGUF has a forward dividend yield of 2336.45% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 2333.69 percentage points.

Home › Compare › CLGUF vs MRK

CLGUF vs MRK: Dividend Comparison 2026

CLGUF yields 2336.45% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CLGUF wins by $42604535760.36M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CLGUF

● Live price

2336.45%

Share price

$0.09

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$42604535760.42M

Annual income

$39,296,041,752,408,910.00

Full CLGUF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — CLGUF vs MRK

📍 CLGUF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CLGUF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CLGUF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CLGUF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLGUF

Annual income on $10K today (after 15% tax)

$198,598.13/yr

After 10yr DRIP, annual income (after tax)

$33,401,635,489,547,576.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, CLGUF beats the other by $33,401,635,489,539,250.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLGUF + MRK for your $10,000?

CLGUF: 50%MRK: 50%

100% MRK50/50100% CLGUF

Portfolio after 10yr

$21302267880.24M

Annual income

$19,648,020,876,209,356.00/yr

Blended yield

92.23%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CLGUF

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLGUF buys

MRK buys

No recent congressional trades found for CLGUF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCLGUFMRK

Forward yield	2336.45% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$42604535760.42M ✓	$56.8K
Annual income after 10y	$39,296,041,752,408,910.00 ✓	$9,798.13
Total dividends collected	$42372331583.64M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CLGUF vs MRK ($10,000, DRIP)

Year	CLGUF Portfolio	CLGUF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$244,345	$233,644.86	$11,206	$366.19	+$233.1K → CLGUF
2	$5,596,956	$5,335,506.59	$12,650	$502.35	+$5.58M → CLGUF
3	$120,208,317	$114,219,574.14	$14,407	$694.19	+$120.19M → CLGUF
4	$2,421,281,629	$2,292,658,729.92	$16,585	$967.82	+$2421.27M → CLGUF
5	$45,749,279,790	$43,158,508,447.52	$19,342	$1,363.89	+$45749.26M → CLGUF
6	$811,068,650,211	$762,116,920,835.57	$22,913	$1,947.19	+$811068.63M → CLGUF
7	$13,495,163,269,967	$12,627,319,814,241.27	$27,662	$2,823.89	+$13495163.24M → CLGUF
8	$210,797,521,966,679	$196,357,697,267,814.40	$34,159	$4,173.35	+$210797521.93M → CLGUF
9	$3,092,050,474,774,347	$2,866,497,126,269,999.50	$43,337	$6,308.80	+$3092050474.73M → CLGUF
10	$42,604,535,760,417,464	$39,296,041,752,408,910.00	$56,776	$9,798.13	+$42604535760.36M → CLGUF

CLGUF vs MRK: Complete Analysis 2026

CLGUF — Stock

Cloud Nine Web3 Technologies Inc. operates as a technology company. It focuses on incorporating various technologies into its current platforms leveraging Web 3.0. Web 3.0 enables a future where decentralized users and machines interact with data, value, and other counterparties through a substrate of peer-to-peer networks without the need for third parties. Cloud Nine Web3 Technologies Inc. has a strategic partnership with Next Decentrum Technologies Inc. The company was incorporated in 2015 and is headquartered in Vancouver, Canada.

Full CLGUF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this CLGUF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLGUF vs SCHD CLGUF vs JEPI CLGUF vs O CLGUF vs KO CLGUF vs MAIN CLGUF vs JNJ CLGUF vs ABBV CLGUF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.